Not enough lashes? Ask your doctor if LATISSE® is right for you.
LATISSE® (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or not enough eyelashes, growing them longer, fuller and darker. It’s a once-a-day treatment that works gradually and effectively. You apply the solution topically to the base of your upper eyelashes, as instructed by your doctor. Then, results start to show in as little as 8 weeks, with full results in 16 weeks.
The science behind LATISSE®.
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.
It’s a product whose time has come.
In 2001, Allergan developed a medicated eye drop used to lower eye pressure (known as IOP or intraocular pressure) in patients with open-angle glaucoma or ocular hypertension. As a result, patients using this medication began experiencing eyelash growth as a side effect. This led Allergan, already a pioneer in eye care, dermatological and aesthetic products, to begin studying its active ingredient. After a clinical trial, LATISSE® earned its FDA approval in December 2008. And since then, approximately 1.5 million bottles of LATISSE® have been prescribed to approximately 350,000 people.
